All Stories

  1. When should a time at risk start in efficacy malaria vaccine trials?

    Article • Vaccine, January 2017, Elsevier

    Dr Dawit A Ejigu

  2. A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

    Article • Vaccine, August 2016, Elsevier

    Dr Dawit A Ejigu

  3. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date

    Article • Drug Design Development and Therapy, July 2016, Dove Medical Press

    Mr Wondmagegn Tamiru Tadesse, Dr Dawit A Ejigu , Mr Yehenew Ebstie

  4. Community-based Rehabilitation Intervention for people with Schizophrenia in Ethiopia (RISE): study protocol for a cluster randomised controlled trial

    Article • Trials, June 2016, Springer Science + Business Media

    Dr Dawit A Ejigu

  5. Task sharing for the care of severe mental disorders in a low-income country (TaSCS): study protocol for a randomised, controlled, non-inferiority trial

    Article • Trials, February 2016, Springer Science + Business Media

    Dr Dawit A Ejigu

  6. Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy

    Article • AIDS, July 2014, Wolters Kluwer Health

    Dr Dawit A Ejigu